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Introduction: Plasma cells residing in inflamed tissues produce antibodies in chronic inflammatory and systemic
autoimmune diseases. This study examined if plasma cells, located within inflamed nasal tissue in granulomatosis
with polyangiitis (GPA), express features potentially associated with the autoimmune and destructive character of
this disease.
Methods: Ig gene mutation patterns of individual tissue-derived plasma cells from GPA (n = 5) were analyzed, by
using laser-assisted microdissection followed by semi-nested polymerase chain reaction (PCR). Signs of B-lymphocyte
maturation (ectopic lymphoid structures, ELS) and survival (a proliferation-inducing ligand, APRIL; B-cell maturation
antigen, BCMA; transmembrane-activator and calcium modulator and cyclophilin interactor, TACI; receptor activator of
nuclear factor κB ligand, RANKL) were examined in nasal tissues or serum, respectively, by using immunohistochemistry/
fluorescence and enzyme-linked immunosorbent assay, ELISA.
Results: Plasma-cell derived Ig genes (light- and heavy-chain pairs, n = 4; heavy chains, n = 33) resembled mutation
patterns seen in other autoimmune diseases, predominantly displaying selection against replacement mutations within
the framework region of Ig genes (10 of 15), which is responsible for structural integrity. Ectopic lymphoid structures
were similar between GPA and a disease control (that is, unspecific chronic rhinosinusitis. However, histomorphologic
features distinguishing GPA from rhinosinusitis (that is, neutrophilic microabscess and granuloma) expressed considerable
amounts of membrane-associated and secreted APRIL, respectively. The latter was co-localized with CD138 and found in
close proximity to cells expressing IgG, TACI, and BCMA. Interestingly, plasma cells strongly expressed receptor activator
of nuclear factor κB ligand (RANKL), apart from fibroblast-like cells.
Conclusions: Plasma cells within granulomatous inflammation appear to display features that might be required for
autoreactivity and, possibly, RANKL-mediated destruction in GPA.Introduction
Granulomatosis with polyangiitis (GPA/Wegener) is a
multisystem disease of unknown etiology, characterized
by granulomatous manifestations in the respiratory tract
and systemic necrotizing vasculitis. Anti-neutrophilic
cytoplasmic antibodies (ANCA) with specificity for
proteinase 3 are a defining feature of this disease, but other* Correspondence: antje.mueller@uksh.de
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reproduction in any medium, provided the orautoantibodies are found as well [1,2]. Clinical symptoms
are often due to necrotizing granulomatous inflam-
mation, predominantly in the respiratory tract, leading to
fibroblast-mediated cartilage/bone destruction and to vas-
culitis, probably autoantibody mediated [1,3,4]. Inflamed
tissue within nasal mucosa displays the pathognomonic
triad consisting of ill-defined granuloma, geographic
necrosis, and vasculitis [5], accompanied by prominent
neutrophil infiltration (microabscess) and lymphoplasmo-
cytic aggregates [3,5,6].
Recently, we detected mutated Ig variable (V) region
genes in nasal tissue in GPA, and some of the CD20+ B
cells produced autoantibodies [7]. Thus, we assumedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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probably via ectopic lymphoid structures (ELS). ELS are
considered the morphologic basis of B-cell autoimmun-
ity in rheumatoid arthritis (RA) [8]; however, this associ-
ation was questioned [9]. Further, B cells can be depleted
via anti-CD20 therapy, inducing remission in GPA [10].
Nonetheless, relapses occur, suggesting that plasma cells,
surviving in niches and producing autoantibodies [11],
could be responsible. Cells expressing B cell-activating fac-
tor, B cell-activating factor receptor, and a proliferation-
inducing ligand (APRIL) were shown in GPA mucosa [12],
promoting the niche concept. To search for alterations,
plasma cells derived from inflamed nasal tissue in GPA
were analyzed in terms of mutation pattern of their Ig
genes and compared with controls [13], after laser-assisted
microdissection and semi-nested PCR.
To investigate a relevance for B-cell autoimmunity in
GPA, ELS were examined and compared with a non-
autoimmune disease control, by using immunohistochem-
istry. Because plasma cell survival is mediated through
APRIL signaling via B-cell maturation antigen (BCMA)
or transmembrane-activator and calcium modulator and
cyclophilin ligand interactor (TACI) [14], their expressions
were investigated, by using immunohistochemistry/-
fluorescence and Elisa. Because APRIL binding to BCMA
led to elevated receptor activator of nuclear factor κB lig-
and (RANKL) levels [15], its tissue expression was evalu-
ated as well.
Our results indicate altered Ig V gene-mutation pat-
terns in plasma cells residing in inflamed nasal tissue.
The presence of ELS in GPA suggests the possibility of a
role in developing autoreactive B cells [7]; however, the
phenotypical properties of ELS did not differ from a
non-autoimmune inflammatory disorder (that is, chronic
rhinosinusitis (CRS)). In contrast, plasma cell survival
seems to be supported by distinct histomorphologic
structures in GPA (that is, neutrophilic microabscess
and granuloma), expressing the survival factor APRIL.
Co-localization of APRIL and CD138 allows recognition
by the receptor TACI. RANKL expression by cells with a
plasma cell-like appearance might serve as an indication
of binding between APRIL and the receptor BCMA.
Methods
Patients and tissues
Sinunasal biopsies were taken from 26 GPA patients, 20
patients with unspecific CRS, and one patient each with
rheumatoid arthritis (RA) and sarcoidosis. Patients’ writ-
ten consent according to the Declaration of Helsinki was
obtained, and the study design was approved by the eth-
ics committee of the University of Luebeck (07–058).
Patient characteristics are summarized (Additional file 1:
Table S1). Formalin-fixed and paraffin-embedded nasal
and lung biopsies of 22 GPA patients were selected forimmunostaining (Additional file 1: Table S2), and freshly
frozen nasal biopsies of five GPA patients (proteinase 3-
ANCA+) were chosen for Ig gene analysis. Markers of
the histomorphologic triad of GPA were not present in
these five biopsies, but lymphoplasmocytic infiltrates, and
three patients had a history of GPA-related histology.
Isolation and characterization of plasma-cell-derived Ig V
region genes
This was conducted as described before [6], with the
exception of staining with anti-CD138 (MI15; Dako,
Hamburg, Germany) followed by anti-mouse HRP-
conjugate (Zytomed Systems, Berlin, Germany) and ami-
noethylcarbazole (Dako). PCR products were identified
by using IMGT/V-Quest [16]. All sequences have been




The following primary mouse, rabbit, or rat antibodies
were used: anti-CD3 (Dako), anti-CD4 (4B12; Biogenex,
Fremont, CA, USA), anti-CD8 (BC/1A5; Biocare Medical,
Concord, MA, USA), anti-CD20 (L26), anti-CD21 (1 F8),
anti-CD35 (Ber-MAC-DRC), anti-CD57 (TB01), anti-
CD68 (PGM1), (all Dako), anti-CD23 (SP23; Biomol,
Hamburg, Germany), anti-CD38 (38C03; Labvision,
Dreieich, Germany), anti-peripheral node addressin (PNAd:
MECA-79; BD, Heidelberg, Germany), anti-APRIL (Stalk-1/
ED; MyBioSource, San Diego, CA, USA; Ap2; Enzo
Life Sciences, Lörrach, Germany), anti-RANKL (MIH24;
Biolegend, San Diego, CA, USA), anti-TACI (R&D
Systems, Wiesbaden, Germany), and anti-BCMA (Sigma,
München, Germany). Neutrophils were detected enzymati-
cally by using naphthol ASD chloroacetate [17]. After
deparaffinization and rehydration of sections (3 to 4 μm),
antigens were retrieved by heating in pH 6.0 or pH 9.0
buffer. Nonspecific binding was minimized by using
protein block (Dako). To provide for controls, sections
were stained with appropriate isotype controls (Dako;
AbD Serotec, Düsseldorf, Germany) instead of primary
antibodies. Stainings for CD marker, PNAd, APRIL, TACI,
and RANKL were carried out by applying a peroxidase-
based protocol [6]. CXCL13 and CCL21 were stained
with goat anti-CXCL13 and goat anti-CCL21 (R&D
Systems), respectively, by using an avidin/biotinylated
enzyme complex-based protocol [4]. Double stainings
for secreted APRIL and goat anti-human IgG F(abʹ)2
fragment (Dianova, Hamburg, Germany), as well as for
CD138 and BCMA, were performed by using the Envision
Doublestain kit (Dako) according to the manufacturer’s
instructions, with the exception of using donkey anti-
goat-HRP-conjugated antibody (Dianova) for IgG detec-
tion. Images were acquired by using a slide scanner and
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Double immunofluorescence staining
In brief, sections were stained for CD138 followed by
donkey anti-mouse AF488 Fab fragment (Dianova).
Thereafter, secreted APRIL was stained by using Ap2
antibody followed by goat anti-mouse AF568 IgG.
Nuclear staining was done by using 4′,6-diamidin-2-
phenylindol (DAPI) followed by mounting with ProLong
Gold reagent (all Life Technologies, Karlsruhe, Germany).
Sections were viewed on a laser-scanning microscope IX81
and confocal stacks modeled with the FV10-ASW v03 soft-
ware (Olympus, Hamburg, Germany).
ELISA
APRIL was measured in sera of GPA patients (n = 20),
CRS patients (n = 10), and healthy controls (n = 13) by
using an ELISA according to the manufacturer’s instruc-
tions (eBioscience, Frankfurt/M, Germany).
Results
Altered mutation pattern of plasma cell-derived Ig genes
in nasal tissue in GPA
Of 41 productively rearranged Ig V region gene frag-
ments, representing 37 dispersely distributed CD138+
plasma cells, 15 (37%) yielded significantly mutated Ig
genes compared with corresponding germline genes
(Table 1; Additional file 1: Table S3). Selection was cal-
culated based on replacement to silent mutation ratios
in a complementarity-determining region (CDR) and
framework region (FR), according to [18]. Regarding theTable 1 Overview of selection (P values) against or for
replacement mutations within framework region (FR) and
CDR of plasma cell-derived Ig genes in nasal tissue in GPAa
V region
subfamily
FR negative CDR negative CDR positive
VH1-3 P≤ 0.002b P ≤ 0.03b
VH1-46 P < 0.02
VH1-69 P≤ 0.01(2),e P ≤ 0.02 (2),f
P < −0.05
P < 0.01
VH3-23 P ≤ 0.02c P ≤ 0.01c
VH3-30 P ≤ 0.001
VH3-74 P ≤ 0.02
VH4-39 P < 0.02
VH4-4 P ≤ 0.01d P ≤ 0.03d
Vκ1-39 P < 0.03
Vκ2-28 P < 0.04
aThe focused binomial test [18] was used to estimate selection, yielding P values
with statistical significance at <0.05.
b,c,dThese three VH genes showed negative selection in both FR and CDR.
e,fTwo and two individual VH genes each, respectively, displayed identical
P values.FR, which determines the shape of the B-cell receptor,
none of the 15 genes exhibited selection for replacement
mutations, whereas selection against replacement muta-
tions was detected in 10 genes. Mean mutation frequencies
of L- and H-chain genes were 3% and 8%, respectively. Al-
though statistically insignificant (probably due to the low
number), VH genes showed overrepresentation of VH1
versus underrepresentation of VH4 rearrangements and a
prolonged CDR3 (Additional file 1: Figure S1).
Ectopic lymphoid structures are similar between GPA and
disease control
ELSs were frequently present within granulomatous in-
flammation, ranging from aggregates to highly organized
forms. Nonetheless, this was also true for the disease
control, unspecific CRS (Figure 1A-H; Additional file 1:
Table S4). Almost all tissues exhibited lymphocytic ag-
gregates resembling follicular structures, most of them
characterized by networks of CD21+ follicular dendritic
cells (FDCs). High endothelial venules expressing PNAd
were found in the majority of tissues, often located close
to follicular structures. Cells staining positive for the
lymphoid chemokine CXCL13 [8] were indicative of
FDCs, but networks could not be detected (Additional
file 1: Figure S2A-B). Although vessels expressing the
lymphoid chemokine CCL21 were observed (Additional
file 1: Figure S2C-D), perivascular CCL21+ stromal cells,
being described as important for ELSs in RA [19], could
not be found. Plasma cell infiltrates were seen in nearly
all tissues.
Neutrophils, macrophages, and giant cells forming
granulomatous inflammation are major sources of APRIL
Our results demonstrated that PMNs, accumulating
in microabscesses, are a major source of membrane-
associated APRIL in GPA (Figure 2A,B; Additional file 1:
Table S5). Diffusely distributed neutrophils expressing
membrane-associated APRIL were also present in CRS
(Additional file 1: Figure S3A). Granulomas, composed of
macrophages and giant cells, displayed substantial expres-
sion of secreted APRIL (Figure 2C,D; Additional file 1:
Table S3). Because tissue-infiltrating neutrophils were
negative for secreted APRIL, we assumed that after furin
cleavage, APRIL is secreted and taken up by other cells, a
mechanism that has been suggested before [20]. Further,
epithelial cells expressed secreted APRIL in GPA and CRS
(Additional file 1: Figure S3B). Increased amounts of
APRIL were also secreted in peripheral blood in GPA when
compared with CRS and HC (Additional file 1: Figure S4).
APRIL receptors (BCMA, TACI) and RANKL are expressed
by plasma cells
BCMA was expressed by plasma cells (Figure 2E), lympho-








Figure 1 ELSs in nasal tissues do not differ between GPA and CRS. (A through D) Immunohistochemistry of GPA displaying CD3+ T
lymphocytes (A, brown) surrounding a primary CD20+ B-cell follicle (B, brown color) with a CD21+ FDC network (C, brown), which could be
located in proximity to PNAd+ high endothelial venules (D, brown). (E through H) Immunohistochemistry of CRS showing CD3+ T lymphocytes
(E, brown) surrounding a primary CD20+ B-cell follicle (F, brown) with a CD21+ FDC network (G, brown) that could be located near PNAd+ high
endothelial venules (H, brown). Nuclei are stained in blue with hematoxylin (Figure 1A-H, Figure 2A-G, K, L).
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RANKL expression was found in cells exhibiting a
plasma cell-like morphology (Figure 2F,G). The receptor
TACI recognizes multi-/oligomerized APRIL cross-
linked via heparan sulfate proteoglycans such as synde-
cans [14]. Syndecan-1 (CD138) and secreted APRIL were
colocalized on different cell types, including plasma cells
(Figure 2H through J). Moreover, secreted APRIL was
found in the direct vicinity of IgG+ cells (Figure 2K).
Thus, clustered APRIL could interact with TACI, which
was expressed by cells displaying a plasma-cell-like
morphology (Figure 2L). Regarding CRS, cells expressingBCMA, RANKL, or TACI were present (Additional file 1:
Figure S5). Additional experiments are warranted to deter-
mine whether apparent differences (cell type, numbers) are
relevant in comparison with GPA.
Discussion
Based on previous findings in GPA [7,12] and similarly
to other chronic inflammatory diseases [8,20,21], we
hypothesize that nonlymphoid tissue, such as the nasal
mucosa in GPA, is a place where B/plasma cell-mediated
autoreactivity could develop and/or be present. Overall,









Figure 2 Granulomatous inflammation supports plasma cell survival in GPA. (A through D) Immunohistochemistry displaying neutrophils
(A, red arrows) forming a microabscess and strong expression of membrane-associated APRIL (B, brown arrows) in the area corresponding to the
neutrophilic microabscess. Immunohistochemistry showing macrophages and giant cells forming a granuloma (C, brown) and strong expression
of secreted APRIL (D, brown arrows) by macrophages and giant cells. (E through G) Double immunohistochemistry displaying BCMA (E, brown)
in close vicinity to CD138 (E, red). Cells positive for BCMA and CD138 are marked (arrows). Immunohistochemistry indicating different types of
RANKL-expressing cells, close to bone (b) (F, brown arrows) and with a plasma cell-like morphology (G, brown arrows). (H through J)
Immunofluorescence staining demonstrating that CD138 (H, green) is co-localized with secreted APRIL (I, red color) on plasma cells (J, merger
of H + I, arrow). Nuclei are stained in blue with 4′,6-diamidin-2-phenylindol (DAPI). Scale bar, 5 μm. (K, Double immunohistochemistry depicting that
secreted APRIL (red) is expressed in direct vicinity of IgG+ cells (brown arrows). (L) Immunohistochemistry showing that TACI+ cells (brown arrows)
exhibit a plasma cell-like appearance.
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for plasma cell development and survival in nasal tissue
in GPA. In more detail and regarding genetic features
of plasma cells, we observed similarities between our
current and previous [7] results, a meta-analysis of other
studies in various autoimmune diseases [13], and findings
in rheumatoid synovium [22]. Despite these similarities
(showing, for instance, a prevalence of selection against
mutations in the framework region of Ig V genes, which
is not seen in controls), we are well aware that altered
mutation patterns in the Ig V gene regions in themselves
are not sufficient to indicate autoreactivity in the granu-
lomatous inflammation. Moreover, aside from the muta-
tion rate, physicochemical effects of mutations leading to
amino acid exchanges have to be considered as well [13].
In general, to demonstrate autoreactivity, this must be
validated by cloning and expressing the antibodies from
the isolated plasma cells and testing them for (auto)anti-
gen specificity, which is part of ongoing work. Apart from
a possible association with autoreactivity, mutations
in Ig V gene regions could be induced by bacterial infec-
tions such as S. aureus, which has been linked to GPA
pathogenesis. Superantigens from S. aureus-stimulating T
cells have been demonstrated as a trigger for relapses [23].
Nonetheless, it remains to be determined whether B-cell
superantigens (for example, staphylococcal protein A,
staphylococcal enterotoxin D) [24] might play a role in
GPA, which, for example, would lead to alterations in the
Ig V gene repertoire of B cells.
Besides autoantibody-producing plasma cells, ELS
have been implicated in B-cell autoimmunity [8]; how-
ever, this is controversially discussed [9]. Although our
findings show that ELS are present within granuloma-
tous inflammation and could thus be involved in selec-
tion and maturation of B lymphocytes, the results also
support the concept that lymphoid structures are a re-
sult of chronic inflammation [25]. To understand the
role of ELS in GPA in terms of assisting in the develop-
ment of (auto)immune reactions, more experimental
work is needed. Of note, the presence of CD20+ cell ag-
gregates and organized ELS in GPA contrasts with an-
other study [12], reporting that B cells mostly are
isolated cells. Further, a difference in CCL21 expression
between rheumatoid synovium and nasal tissue in GPA
with respect to perivascular stromal cells matches a
polymorphism in the CCL21 gene, which is associated
with RA but not GPA [26]. Based on our results and
corresponding to other studies [9,22], we assume that
highly organized ELS are not a specific prerequisite for
maturation of (autoreactive) B lymphocytes in GPA.
Regarding plasma cell survival and extending previous
findings [12] by discriminating between membrane-
associated and secreted APRIL [20], GPA-characteristic
histomorphology (neutrophilic microabscess, granuloma)seems to concentrate considerable amounts of APRIL,
which is comparable with synovium [20], but differs from
CRS tissue. The expression of RANKL by fibroblast-like
and other cells could be due to an interaction between
APRIL and its receptor BCMA, as has been demonstrated
for synovial fibroblasts in RA [15]. A contribution of
RANKL+ plasma cells to destructive or other pathogenic
mechanisms in GPA requires further investigation.
Conclusions
Although tissue-residing plasma cells in GPA display
genetic features (indicated by their Ig V region gene-
mutation pattern) that are similar to other autoimmune
diseases, plasma cell (auto)reactivity in nasal mucosa re-
mains to be demonstrated. A lack of difference between
GPA and disease control in terms of ELS phenotype points
to less relevance for autoimmune-specific processes.
Neutrophils, macrophages, and giant cells forming GPA-
characteristic granulomatous inflammation could support
survival of plasma cells by providing considerable amounts
of both membrane-associated and secreted APRIL. The lat-
ter might subsequently interact with the receptors TACI
and/or BCMA, expressed by plasma cells. The strong ex-
pression of RANKL by plasma cell-like cells, which could
be due to binding between APRIL and BCMA, might indi-
cate an unrecognized role for these cells in destructive
mechanisms in GPA.
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Table S2. Detailed overview about characteristic histomorphologic
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in GPA showing the (A) number of somatic mutations, (B) VH gene
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